On this episode of Managed Care Cast, we speak with Tim Gronniger, the CEO of Caravan Health, about what to look for as accountable care organizations (ACOs) and policy makers try to encourage more providers to join value-based care arrangements.
The “muscles” that were created in value-based care programs in the years before the pandemic have been helpful to accountable care organizations (ACOs) in dealing with the turmoil in health care delivery, according to our guest on this week’s Managed Care Cast.
Tim Gronniger, MPP, MHSA, the CEO of Caravan Health, discusses what may come next (or ideally might come next) as ACOs move forward as the United States adjusts to an endemic phase of COVID-19. We discuss financing and policy and what is needed to achieve CMS’ goal of furthering the shift to ACOs by 2030.
Gronniger, former chief of staff and director of Delivery System Reform at CMS in the Obama administration, also discusses the company’s recent acquisition by Signify Health.
Listen above or through one of these podcast services:
Perioperative Nivolumab Boosts NSCLC Survival: CheckMate 77T Trial
May 16th 2024This interim analysis of the CheckMate 77T trial, outcomes were compared between adult patients receiving neoadjuvant nivolumab plus chemotherapy or neoadjuvant chemotherapy plus placebo for resectable non–small cell lung cancer (NSCLC).
Read More
Frameworks for Advancing Health Equity: Urban Health Outreach
May 9th 2024In the series debut episode of "Frameworks for Advancing Health Equity," Mary Sligh, CRNP, and Chelsea Chappars, of Allegheny Health Network, explain how the Urban Health Outreach program aims to improve health equity for individuals experiencing homelessness.
Listen
Decitabine, Venetoclax Combo Boosts Survival in Patients With AML and MDS
May 16th 2024Study findings demonstrate that combining decitabine with venetoclax enhances molecular response rates in patients with acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS), correlating strongly with improved clinical outcomes and overall survival.
Read More